Pfizer, BioNTech’s COVID-19 Vaccine Shows 90% Effectiveness After Trials
A vaccine jointly developed by Pfizer and BioNTech has proved 90 percent effective in preventing COVID-19 infections in ongoing Phase 3 trials.
The companies announced this on Monday as coronavirus cases keep soaring across the world.…